O’Melveny & Myers LLP represented China Kanghui Holdings (Kanghui) in entering into a merger agreement with Medtronic, Inc., whereby Kanghui will be acquired by Medtronic. The transaction is valued at approximately US$816 million, and expected to close before the end of 2012.
The San Francisco-based O’Melveny team was led by partners Paul Scrivano and Portia Ku.
Related Posts:
- O’Melveny Represents BGI-Shenzhen in Merger Agreement with Complete Genomics
- O’Melveny Represents Financial Advisor to PLX Technology in its Acquisition by Integrated Device Technology
- O’Melveny Represents Microsemi Corporation in Agreement to Acquire Zarlink Semiconductor, Inc.
- O’Melveny Represents Thornridge Holdings Limited in Connection with the Proposed Acquisition of Assisted Living Concepts by TPG
- O’Melveny Represents TRI Pointe Independent Directors in US$2.7 Billion Combination Transaction